During the past decade, Hangang Sacred Heart Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hangang Sacred Heart Hospital" #1 sponsor was "Hangang Sacred Heart Hospital" with 13 trials, followed by "Seung-Jung Park" with 5 trials sponsored, "CardioVascular Research Foundation, Korea" with 2 trials sponsored, "Asan Medical Center" with 1 trials sponsored and "Biosolution Co., Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hangang Sacred Heart Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 5 trials as a collaborator, "National Research Foundation of Korea" with 5 trials as a collaborator, "Hallym University" with 3 trials as a collaborator, "Asan Medical Center" with 2 trials as a collaborator and "Ministry of Health, Republic of Korea" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Hangang Sacred Heart Hospital" are "Coronary Artery Disease" (5 trials), "Burns" (3 trials), "Burn Scar" (2 trials), "Burn Surgery" (2 trials) and "Brain Ischemia" (1 trials). Many other conditions were trialed in "Hangang Sacred Heart Hospital" in a lesser frequency.

Most popular intervention types in "Hangang Sacred Heart Hospital" are "Device" (8 trials), "Drug" (6 trials), "Other" (6 trials), "Diagnostic Test" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Extracorporeal shock wave therapy" (3 trials), "Aspirin monotherapy" (2 trials), "Aspirin,Clopidogrel" (2 trials), "Cypher" (2 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hangang Sacred Heart Hospital" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Hangang Sacred Heart Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Hangang Sacred Heart Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hangang Sacred Heart Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 11 trials that are defined as “Not Applicable".